| Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer SA Eccles, EO Aboagye, S Ali, AS Anderson, J Armes, F Berditchevski, ... Breast Cancer Research 15, 1-37, 2013 | 509 | 2013 |
| Rapid chromosome territory relocation by nuclear motor activity in response to serum removal in primary human fibroblasts IS Mehta, M Amira, AJ Harvey, JM Bridger Genome biology 11, 1-17, 2010 | 216 | 2010 |
| mTOR function and therapeutic targeting in breast cancer SH Hare, AJ Harvey American journal of cancer research 7 (3), 383, 2017 | 180 | 2017 |
| The clinicopathological significance of lamin A/C, lamin B1 and lamin B receptor mRNA expression in human breast cancer U Wazir, MH Ahmed, JM Bridger, A Harvey, WG Jiang, AK Sharma, ... Cellular & molecular biology letters 18, 595-611, 2013 | 132 | 2013 |
| Use of RNA interference to validate Brk as a novel therapeutic target in breast cancer: Brk promotes breast carcinoma cell proliferation AJ Harvey, MR Crompton Oncogene 22 (32), 5006-5010, 2003 | 95 | 2003 |
| A study of death by anoikis in cultured epithelial cells AJ Bretland, J Lawry, RM Sharrard Cell proliferation 34 (4), 199-210, 2001 | 80 | 2001 |
| Brk protects breast cancer cells from autophagic cell death induced by loss of anchorage AJ Harvey, CJ Pennington, S Porter, RS Burmi, DR Edwards, W Court, ... The American journal of pathology 175 (3), 1226-1234, 2009 | 64 | 2009 |
| Targeting primary human leukaemia cells with RNA interference: Bcr‐Abl targeting inhibits myeloid progenitor self‐renewal in chronic myeloid leukaemia cells JME Withey, SB Marley, J Kaeda, AJ Harvey, MR Crompton, MY Gordon British journal of haematology 129 (3), 377-380, 2005 | 58 | 2005 |
| Differential expression of mTOR signalling components in drug resistance in ovarian cancer H Foster, HM Coley, A Goumenou, G Pados, A Harvey, E Karteris Anticancer research 30 (9), 3529-3534, 2010 | 54 | 2010 |
| Identification of cancer biomarkers of prognostic value using specific gene regulatory networks (GRN): a novel role of RAD51AP1 for ovarian and lung cancers D Chudasama, V Bo, M Hall, V Anikin, J Jeyaneethi, J Gregory, G Pados, ... Carcinogenesis 39 (3), 407-417, 2018 | 52 | 2018 |
| The non-random repositioning of whole chromosomes and individual gene loci in interphase nuclei and its relevance in disease, infection, aging, and cancer JM Bridger, HD Arican-Gotkas, HA Foster, LS Godwin, A Harvey, IR Kill, ... Cancer Biology and the Nuclear Envelope: Recent Advances May Elucidate Past …, 2014 | 47 | 2014 |
| The Brk protein tyrosine kinase as a therapeutic target in cancer: opportunities and challenges AJ Harvey, MR Crompton Anti-cancer drugs 15 (2), 107-111, 2004 | 46 | 2004 |
| Regulation of prostatic stromal cell growth and function by transforming growth factor beta (TGFβ) HC Klingler, AJ Bretland, SV Reid, CR Chapple, CL Eaton The Prostate 41 (2), 110-120, 1999 | 41 | 1999 |
| Antimicrobial carbon nanodots: Photodynamic inactivation and dark antimicrobial effects on bacteria by brominated carbon nanodots R Knoblauch, A Harvey, E Ra, KM Greenberg, J Lau, E Hawkins, ... Nanoscale 13 (1), 85-99, 2021 | 36 | 2021 |
| HIF-1α-independent hypoxia-induced rapid PTK6 stabilization is associated with increased motility and invasion IM Pires, NJG Blokland, AWT Broos, FA Poujade, JM Senra, SA Eccles, ... Cancer biology & therapy 15 (10), 1350-1357, 2014 | 28 | 2014 |
| Role of endogenous transforming growth factor β (TGFβ) 1 in prostatic stromal cells AJ Bretland, SV Reid, CR Chapple, CL Eaton The Prostate 48 (4), 297-304, 2001 | 26 | 2001 |
| Overview of cell signaling pathways in cancer AJ Harvey Predictive Biomarkers in Oncology: Applications in Precision Medicine, 167-182, 2019 | 22 | 2019 |
| Differential expression of placental glucocorticoid receptors and growth arrest‐specific transcript 5 in term and preterm pregnancies: evidence for involvement of maternal stress D Mparmpakas, E Zachariades, G Sotiriadis, A Goumenou, AJ Harvey, ... Obstetrics and Gynecology International 2014 (1), 239278, 2014 | 19 | 2014 |
| Jasmonates induce Arabidopsis bioactivities selectively inhibiting the growth of breast cancer cells through CDC6 and mTOR M Bömer, I Pérez‐Salamó, HV Florance, D Salmon, JH Dudenhoffer, ... New Phytologist 229 (4), 2120-2134, 2021 | 18 | 2021 |
| Expression of mTOR and downstream signalling components in the JEG-3 and BeWo human placental choriocarcinoma cell lines D Mparmpakas, E Zachariades, H Foster, A Kara, A Harvey, A Goumenou, ... International journal of molecular medicine 25 (1), 65-69, 2010 | 18 | 2010 |
